Literature DB >> 11143526

[Endoscopic pretherapeutic clipping for gastrointestinal tumors. A method for exact definition of the target volume].

M Riepl1, A Pietsch, G Klautke, R Fehr, R Fietkau.   

Abstract

BACKGROUND: In many cases it is not possible to exactly define the extension of carcinoma of the gastrointestinal tract with the help of computertomography scans made for 3-D-radiation treatment planning. Consequently, the planning of external beam radiotherapy is made more difficult for the gross tumor volume as well as, in some cases, also for the clinical target volume. PATIENTS AND METHODS: Eleven patients with macroscopic tumors (rectal cancer n = 5, cardiac cancer n = 6) were included. Just before 3-D planning, the oral and aboral border of the tumor was marked endoscopically with hemoclips. Subsequently, CT scans for radiotherapy planning were made and the clinical target volume was defined. Five to 6 weeks thereafter, new CT scans were done to define the gross tumor volume for boost planning. Two investigators independently assessed the influence of the hemoclips on the different planning volumes, and whether the number of clips was sufficient to define the gross tumor volume.
RESULTS: In all patients, the implantation of the clips was done without complications. Start of radiotherapy was not delayed. With the help of the clips it was possible to exactly define the position and the extension of the primary tumor. The clinical target volume was modified according to the position of the clips in 5/11 patients; the gross tumor volume was modified in 7/11 patients. The use of the clips made the documentation and verification of the treatment portals by the simulator easier. Moreover, the clips helped the surgeon to define the primary tumor region following marked regression after neoadjuvant therapy in 3 patients.
CONCLUSIONS: Endoscopic clipping of gastrointestinal tumors helps to define the tumor volumes more precisely in radiation therapy. The clips are easily recognized on the portal films and, thus, contribute to quality control.

Entities:  

Mesh:

Year:  2000        PMID: 11143526     DOI: 10.1007/pl00002319

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  5 in total

1.  Role of clip markers placed by endoscopic ultrasonography in contouring gross tumor volume for thoracic esophageal squamous cell carcinoma: one prospective study.

Authors:  Yong Guan; Jing Wang; Fuliang Cao; Xi Chen; Yuwen Wang; Shengpeng Jiang; Daguang Zhang; Wencheng Zhang; Zhoubo Guo; Ping Wang; Qingsong Pang
Journal:  Ann Transl Med       Date:  2020-09

2.  Effect of neoadjuvant chemoradiation on postoperative fecal continence and anal sphincter function in rectal cancer patients.

Authors:  Alexander P Pietsch; Rainer Fietkau; Günther Klautke; Thomas Foitzik; Ernst Klar
Journal:  Int J Colorectal Dis       Date:  2007-05-12       Impact factor: 2.571

3.  Gold markers for tumor localization and target volume delineation in radiotherapy for rectal cancer.

Authors:  Hilke Vorwerk; Thorsten Liersch; Hilka Rothe; Michael Ghadimi; Hans Christiansen; Clemens Friedrich Hess; Robert Michael Hermann
Journal:  Strahlenther Onkol       Date:  2009-02-25       Impact factor: 3.621

4.  Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer.

Authors:  G Klautke; P Feyerherd; K Ludwig; F Prall; T Foitzik; R Fietkau
Journal:  Br J Cancer       Date:  2005-04-11       Impact factor: 7.640

5.  Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II study.

Authors:  G Klautke; U Küchenmeister; T Foitzik; K Ludwig; F Prall; E Klar; R Fietkau
Journal:  Br J Cancer       Date:  2006-04-10       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.